{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:42:56Z","timestamp":1790678576740,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["YA-24659157"],"award-info":[{"award-number":["YA-24659157"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.canlet.2015.11.020","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T22:10:13Z","timestamp":1448316613000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells"],"prefix":"10.1016","volume":"371","author":[{"given":"Haruka","family":"Shinohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minami","family":"Kumazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Sugito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kuranaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Naoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Akao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.11.020_bib0010","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2015.11.020_bib0015","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.020_bib0020","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.1038\/sj.onc.1206086","article-title":"Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571","volume":"21","author":"Nimmanapalli","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.11.020_bib0025","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1038\/cddis.2013.60","article-title":"Targeting cellular metabolism to improve cancer therapeutics","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.canlet.2015.11.020_bib0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.11.020_bib0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.canlet.2015.11.020_bib0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: Warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.11.020_bib0045","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.canlet.2015.11.020_bib0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.11.020_bib0055","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1073\/pnas.0914845107","article-title":"The alternative splicing repressors hnRNP A1\/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism","volume":"107","author":"Clower","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2015.11.020_bib0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2015.01.039","article-title":"Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia","volume":"360","author":"Shinohara","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.11.020_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature08268","article-title":"Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment","volume":"461","author":"Schafer","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.11.020_bib0070","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1038\/sj.onc.1208622","article-title":"The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation","volume":"24","author":"Buzzai","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.11.020_bib0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature11066","article-title":"AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress","volume":"485","author":"Jeon","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.11.020_bib0080","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1126\/science.1056843","article-title":"Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2","volume":"291","author":"Abu-Elheiga","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.canlet.2015.11.020_bib0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/onc.2012.70","article-title":"S6K1 determines the metabolic requirements for BCR-ABL survival","volume":"32","author":"Barger","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.11.020_bib0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI38942","article-title":"Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction","volume":"120","author":"Samudio","year":"2010","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2015.11.020_bib0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2015.11.020_bib0100","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.2882","article-title":"A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance","volume":"18","author":"Ito","year":"2012","journal-title":"Nat. Med"},{"key":"10.1016\/j.canlet.2015.11.020_bib0105","first-page":"29","article-title":"3-Decenoic acid derivatives induce autophagic cell death through the down-regulation of E2F1","volume":"3","author":"Shinohara","year":"2013","journal-title":"J. Toxicol. Res"},{"key":"10.1016\/j.canlet.2015.11.020_bib0110","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1038\/bcj.2011.16","article-title":"The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells","volume":"1","author":"Kuwatsuka","year":"2011","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.canlet.2015.11.020_bib0115","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1349-7006.2009.01440.x","article-title":"Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD\/SCID\/IL-2Rgammac-\/- mice","volume":"101","author":"Tanizaki","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canlet.2015.11.020_bib0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1388-1981(00)00034-2","article-title":"Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids","volume":"1485","author":"Lea","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2015.11.020_bib0125","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V96.6.2246","article-title":"CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs","volume":"96","author":"Fang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.020_bib0130","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","article-title":"Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML","volume":"118","author":"Helgason","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.020_bib0135","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2010-12-322537","article-title":"BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription","volume":"118","author":"Sheng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.020_bib0140","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth","volume":"108","author":"Sun","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2015.11.020_bib0145","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1158\/1078-0432.CCR-04-0039","article-title":"Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells","volume":"10","author":"Gottschalk","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.11.020_bib0150","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/sj.onc.1208461","article-title":"Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation","volume":"24","author":"Barnes","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.11.020_bib0155","doi-asserted-by":"crossref","first-page":"8647","DOI":"10.1038\/srep08647","article-title":"Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms","volume":"5","author":"Taniguchi","year":"2015","journal-title":"Sci. Rep"},{"key":"10.1016\/j.canlet.2015.11.020_bib0160","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1101\/gad.1987211","article-title":"Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress","volume":"25","author":"Zaugg","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.canlet.2015.11.020_bib0165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","author":"Bonnefont","year":"2004","journal-title":"Mol. Aspects Med"},{"key":"10.1016\/j.canlet.2015.11.020_bib0170","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","article-title":"Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.020_bib0175","doi-asserted-by":"crossref","first-page":"ra73","DOI":"10.1126\/scisignal.2000431","article-title":"Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth","volume":"2","author":"Hitosugi","year":"2009","journal-title":"Sci. Signal"},{"key":"10.1016\/j.canlet.2015.11.020_bib0180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2015.11.020_bib0185","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/0008-5472.CAN-13-0382-T","article-title":"An essential requirement for the SCAP\/SREBP signaling axis to protect cancer cells from lipotoxicity","volume":"73","author":"Williams","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.11.020_bib0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2012.63","article-title":"Regulation of lipid stores and metabolism by lipophagy","volume":"20","author":"Liu","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.canlet.2015.11.020_bib0195","doi-asserted-by":"crossref","first-page":"713","DOI":"10.18632\/oncotarget.333","article-title":"Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy","volume":"2","author":"Chomel","year":"2011","journal-title":"Oncotarget"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515006965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515006965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T18:17:03Z","timestamp":1656353823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515006965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0304383515006965"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.11.020","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}